Your Article Summary
See Latest ArticlesDecreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients
Cytokine, 06/26/09
Singh B et al. - This is the first study to describe a decrease serum level of IL-6 in schizophrenic patients. The study provides the evidence that some kind of immune dysregulation is involved in pathophysiology of schizophrenia. The study also provides the evidence for the immunosuppressive effect of antipsychotic drugs.
Related Articles
Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09
Relevance Score: 93%
Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09
Relevance Score: 92%
Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09
Relevance Score: 91%
Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09
Relevance Score: 91%
Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09
Relevance Score: 91%
Today in Neurologic/Ophthalmic...keeping you current
Receive free subspecialty "5-minute updates" via email
The regulatory role of the MisR/S two-component system in hemoglobin utilization in Neisseria meningitidis
Infection and Immunity, 12/18/09
Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
Journal of Neuroinflammation, 12/16/09
Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease
Journal of Neuroinflammation, 12/14/09